Lapsed Oct 30, 2026 on the fee record · Low confidence
20-year base term ends Dec 8, 2031
Second maintenance fee unpaid; grace period ended. The USPTO has not yet posted the lapse.
Dec 8, 2011
Oct 30, 2026
Oct 30, 2018
Dec 8, 2031
Its term would have run to Dec 8, 2031: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 8, 2011, when application 13/315,005, the earliest non-provisional in its chain, was filed (this one was filed Apr 25, 2017) | Dec 8, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,598,362, US 9,663,492) | resolves to Dec 8, 2031, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No fee event states this; the fee state is read from the payments the fee record holds; the fee record shows no payment for this window, and USPTO's status still reads "Patented Case" | lapsed Oct 30, 2026 | Low confidence |
| Computed term end | The steps above, in order | Oct 30, 2026 | Low confidence |
This family
| US 8,598,362 | Lapsed on the fee record Dec 2025 | Dec 2025 |
| US 8,921,566 | In force Dec 2031 | Dec 2031 |
| US 9,242,936 | In force no later than Dec 2031 | no later than Dec 2031 |
| US 9,663,492 | Lapsed on the fee record May 2025 | May 2025 |
| US 10,112,925 | this patent Oct 2026 | Oct 2026 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 22, 2017 Reel 42784, frame 34 | Li, Wei; Zhao, Robert Yongxin | ImmunoGen, Inc. | Assignment of Assignor's Interest |
| Apr 6, 2023 Reel 63282, frame 894 | ImmunoGen, Inc.; ImmunoGen Switzerland GmbH | Biopharma Credit PLC | Patent Security Agreement |
| Feb 12, 2024 Reel 66553, frame 109 | Biopharma Credit PLC | ImmunoGen, Inc.; ImmunoGen Switzerland GmbH | Release of Security Interest |
| Feb 12, 2024 reel/frame not recorded | Biopharma Credit PLC | ImmunoGen, Inc. | Release of Security Interest |
| Feb 12, 2024 reel/frame not recorded | Biopharma Credit PLC | ImmunoGen Switzerland GmbH | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 8,598,362, US 9,663,492, ends no earlier than this term, so it caps nothing.